Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Cancer Biopharmaceuticals Market Size Growth Rate by Type (2014-2025) 1.4.2 Biologics 1.4.3 Biosimilars 1.5 Market by Application 1.5.1 Global Cancer Biopharmaceuticals Market Share by Application (2014-2025) 1.5.2 Liquid Cancers 1.5.3 Solid Cancers 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Cancer Biopharmaceuticals Market Size 2.2 Cancer Biopharmaceuticals Growth Trends by Regions 2.2.1 Cancer Biopharmaceuticals Market Size by Regions (2014-2025) 2.2.2 Cancer Biopharmaceuticals Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Cancer Biopharmaceuticals Market Size by by Players 3.1.1 Global Cancer Biopharmaceuticals Revenue by by Players (2014-2019) 3.1.2 Global Cancer Biopharmaceuticals Revenue Market Share by by Players (2014-2019) 3.1.3 Global Cancer Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) 3.2 Cancer Biopharmaceuticals Key Players Head office and Area Served 3.3 Key Players Cancer Biopharmaceuticals Product/Solution/Service 3.4 Date of Enter into Cancer Biopharmaceuticals Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Cancer Biopharmaceuticals Market Size by Type (2014-2019) 4.2 Global Cancer Biopharmaceuticals Market Size by Application (2014-2019) 5 United States 5.1 United States Cancer Biopharmaceuticals Market Size (2014-2019) 5.2 Cancer Biopharmaceuticals Key Players in United States 5.3 United States Cancer Biopharmaceuticals Market Size by Type 5.4 United States Cancer Biopharmaceuticals Market Size by Application 6 Europe 6.1 Europe Cancer Biopharmaceuticals Market Size (2014-2019) 6.2 Cancer Biopharmaceuticals Key Players in Europe 6.3 Europe Cancer Biopharmaceuticals Market Size by Type 6.4 Europe Cancer Biopharmaceuticals Market Size by Application 7 China 7.1 China Cancer Biopharmaceuticals Market Size (2014-2019) 7.2 Cancer Biopharmaceuticals Key Players in China 7.3 China Cancer Biopharmaceuticals Market Size by Type 7.4 China Cancer Biopharmaceuticals Market Size by Application 8 Japan 8.1 Japan Cancer Biopharmaceuticals Market Size (2014-2019) 8.2 Cancer Biopharmaceuticals Key Players in Japan 8.3 Japan Cancer Biopharmaceuticals Market Size by Type 8.4 Japan Cancer Biopharmaceuticals Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Cancer Biopharmaceuticals Market Size (2014-2019) 9.2 Cancer Biopharmaceuticals Key Players in Southeast Asia 9.3 Southeast Asia Cancer Biopharmaceuticals Market Size by Type 9.4 Southeast Asia Cancer Biopharmaceuticals Market Size by Application 10 India 10.1 India Cancer Biopharmaceuticals Market Size (2014-2019) 10.2 Cancer Biopharmaceuticals Key Players in India 10.3 India Cancer Biopharmaceuticals Market Size by Type 10.4 India Cancer Biopharmaceuticals Market Size by Application 11 Central & South America 11.1 Central & South America Cancer Biopharmaceuticals Market Size (2014-2019) 11.2 Cancer Biopharmaceuticals Key Players in Central & South America 11.3 Central & South America Cancer Biopharmaceuticals Market Size by Type 11.4 Central & South America Cancer Biopharmaceuticals Market Size by Application 12 International Players Profiles 12.1 Sanofi 12.1.1 Sanofi Company Details 12.1.2 Company Description and Business Overview 12.1.3 Cancer Biopharmaceuticals Introduction 12.1.4 Sanofi Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.1.5 Sanofi Recent Development 12.2 Johnson & Johnson 12.2.1 Johnson & Johnson Company Details 12.2.2 Company Description and Business Overview 12.2.3 Cancer Biopharmaceuticals Introduction 12.2.4 Johnson & Johnson Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.2.5 Johnson & Johnson Recent Development 12.3 Pfizer 12.3.1 Pfizer Company Details 12.3.2 Company Description and Business Overview 12.3.3 Cancer Biopharmaceuticals Introduction 12.3.4 Pfizer Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.3.5 Pfizer Recent Development 12.4 Novartis 12.4.1 Novartis Company Details 12.4.2 Company Description and Business Overview 12.4.3 Cancer Biopharmaceuticals Introduction 12.4.4 Novartis Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.4.5 Novartis Recent Development 12.5 Merck 12.5.1 Merck Company Details 12.5.2 Company Description and Business Overview 12.5.3 Cancer Biopharmaceuticals Introduction 12.5.4 Merck Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.5.5 Merck Recent Development 12.6 GlaxoSmithKline 12.6.1 GlaxoSmithKline Company Details 12.6.2 Company Description and Business Overview 12.6.3 Cancer Biopharmaceuticals Introduction 12.6.4 GlaxoSmithKline Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.6.5 GlaxoSmithKline Recent Development 12.7 Eli Lilly 12.7.1 Eli Lilly Company Details 12.7.2 Company Description and Business Overview 12.7.3 Cancer Biopharmaceuticals Introduction 12.7.4 Eli Lilly Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.7.5 Eli Lilly Recent Development 12.8 Agios Pharmaceuticals 12.8.1 Agios Pharmaceuticals Company Details 12.8.2 Company Description and Business Overview 12.8.3 Cancer Biopharmaceuticals Introduction 12.8.4 Agios Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.8.5 Agios Pharmaceuticals Recent Development 12.9 Bristol-Myers Squibb 12.9.1 Bristol-Myers Squibb Company Details 12.9.2 Company Description and Business Overview 12.9.3 Cancer Biopharmaceuticals Introduction 12.9.4 Bristol-Myers Squibb Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.9.5 Bristol-Myers Squibb Recent Development 12.10 AstraZeneca 12.10.1 AstraZeneca Company Details 12.10.2 Company Description and Business Overview 12.10.3 Cancer Biopharmaceuticals Introduction 12.10.4 AstraZeneca Revenue in Cancer Biopharmaceuticals Business (2014-2019) 12.10.5 AstraZeneca Recent Development 12.11 Mylan 12.12 LEO Pharma 12.13 Boehringer Ingelheim 12.14 Alexion Pharmaceuticals 12.15 Elusys Therapeutics 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Cancer Biopharmaceuticals Key Market Segments Table Key Players Cancer Biopharmaceuticals Covered Table Global Cancer Biopharmaceuticals Market Size Growth Rate by Type 2019-2025 (Million US$) Figure Global Cancer Biopharmaceuticals Market Share by TypeType in 2018 & 2025 Figure Biologics Figures Table Key Players of Biologics Figure Biosimilars Figures Table Key Players of Biosimilars Table Global Cancer Biopharmaceuticals Market Size Growth by Application 2019-2025 (Million US$) Figure Global Cancer Biopharmaceuticals Market Share by Application in 2018 & 2025 Figure Liquid Cancers Case Studies Figure Solid Cancers Case Studies Figure Cancer Biopharmaceuticals Report Years Considered Table Global Cancer Biopharmaceuticals Market Size 2014-2025 (Million US$) Figure Global Cancer Biopharmaceuticals Market Size and Growth Rate 2014-2025 (Million US$) Table Global Cancer Biopharmaceuticals Market Size by Regions 2019-2025 (Million US$) Table Global Cancer Biopharmaceuticals Market Size by Regions 2019-2025 (Million US$) Table Global Cancer Biopharmaceuticals Market Share by Regions 2014-2019 Figure Global Cancer Biopharmaceuticals Market Share by Regions 2014-2019 Figure Global Cancer Biopharmaceuticals Market Share by Regions 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Cancer Biopharmaceuticals Revenue by by Players (2014-2019) (Million US$) Table Global Cancer Biopharmaceuticals Market Share by by Players (2014-2019) Figure Global Cancer Biopharmaceuticals Market Share by by Players in 2018 Table Global Cancer Biopharmaceuticals by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Cancer Biopharmaceuticals Product/Solution/Service Table Date of Enter into Cancer Biopharmaceuticals Market Table Mergers & Acquisitions, Expansion Plans Table Global Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Global Cancer Biopharmaceuticals Market Size Share by Type (2014-2019) Figure Global Cancer Biopharmaceuticals Market Size Market Share by Type (2014-2019) Table Global Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Global Cancer Biopharmaceuticals Market Size Share by Application (2014-2019) Figure Global Cancer Biopharmaceuticals Market Size Market Share by Application (2014-2019) Figure Global Cancer Biopharmaceuticals Revenue Market Share by Application in 2018 Figure United States Cancer Biopharmaceuticals Market Size 2014-2019 (Million US$) Table United States Key Players Cancer Biopharmaceuticals Revenue (2018-2019) (Million US$) Table United States Key Players Cancer Biopharmaceuticals Market Share (2018-2019) Table United States Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table United States Cancer Biopharmaceuticals Market Share by Type (2014-2019) Table United States Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table United States Cancer Biopharmaceuticals Market Share by Application (2014-2019) Figure Europe Cancer Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Europe Key Players Cancer Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Europe Key Players Cancer Biopharmaceuticals Market Share (2018-2019) Table Europe Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Europe Cancer Biopharmaceuticals Market Share by Type (2014-2019) Table Europe Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Europe Cancer Biopharmaceuticals Market Share by Application (2014-2019) Figure China Cancer Biopharmaceuticals Market Size 2014-2019 (Million US$) Table China Key Players Cancer Biopharmaceuticals Revenue (2018-2019) (Million US$) Table China Key Players Cancer Biopharmaceuticals Market Share (2018-2019) Table China Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table China Cancer Biopharmaceuticals Market Share by Type (2014-2019) Table China Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table China Cancer Biopharmaceuticals Market Share by Application (2014-2019) Figure Japan Cancer Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Japan Key Players Cancer Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Japan Key Players Cancer Biopharmaceuticals Market Share (2018-2019) Table Japan Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Japan Cancer Biopharmaceuticals Market Share by Type (2014-2019) Table Japan Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Japan Cancer Biopharmaceuticals Market Share by Application (2014-2019) Figure Southeast Asia Cancer Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Cancer Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Cancer Biopharmaceuticals Market Share (2018-2019) Table Southeast Asia Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Cancer Biopharmaceuticals Market Share by Type (2014-2019) Table Southeast Asia Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Cancer Biopharmaceuticals Market Share by Application (2014-2019) Figure India Cancer Biopharmaceuticals Market Size 2014-2019 (Million US$) Table India Key Players Cancer Biopharmaceuticals Revenue (2018-2019) (Million US$) Table India Key Players Cancer Biopharmaceuticals Market Share (2018-2019) Table India Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table India Cancer Biopharmaceuticals Market Share by Type (2014-2019) Table India Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table India Cancer Biopharmaceuticals Market Share by Application (2014-2019) Figure Central & South America Cancer Biopharmaceuticals Market Size 2014-2019 (Million US$) Table Central & South America Key Players Cancer Biopharmaceuticals Revenue (2018-2019) (Million US$) Table Central & South America Key Players Cancer Biopharmaceuticals Market Share (2018-2019) Table Central & South America Cancer Biopharmaceuticals Market Size by Type (2014-2019) (Million US$) Table Central & South America Cancer Biopharmaceuticals Market Share by Type (2014-2019) Table Central & South America Cancer Biopharmaceuticals Market Size by Application (2014-2019) (Million US$) Table Central & South America Cancer Biopharmaceuticals Market Share by Application (2014-2019) Table Sanofi Company Details Table Sanofi Revenue in Cancer Biopharmaceuticals Business (2014-2019) (Million US$) Figure Sanofi Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Sanofi Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Johnson & Johnson Recent Development Table Pfizer Company Details Table Pfizer Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Pfizer Recent Development Table Novartis Company Details Table Novartis Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Novartis Recent Development Table Merck Company Details Table Merck Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Merck Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table GlaxoSmithKline Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Eli Lilly Recent Development Table Agios Pharmaceuticals Company Details Table Agios Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure Agios Pharmaceuticals Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Agios Pharmaceuticals Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Cancer Biopharmaceuticals Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Cancer Biopharmaceuticals Business (2014-2019) Table AstraZeneca Recent Development Table Mylan Company Details Table LEO Pharma Company Details Table Boehringer Ingelheim Company Details Table Alexion Pharmaceuticals Company Details Table Elusys Therapeutics Company Details Table Global Cancer Biopharmaceuticals Market Size by Regions (Million US$) 2019-2025 Figure Global Cancer Biopharmaceuticals Market Size Share by Regions (2019-2025) Figure Global Cancer Biopharmaceuticals Market Size Share by Regions in 2025 Figure United States Cancer Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Europe Cancer Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure China Cancer Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Japan Cancer Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Cancer Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure India Cancer Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Cancer Biopharmaceuticals Market Size Forecast (2019-2025)(Million USD) Table Global Cancer Biopharmaceuticals Market Size by Product (2019-2025) (Million US$) Figure Global Cancer Biopharmaceuticals Market Size by Product (2019-2025) Figure Global Cancer Biopharmaceuticals Market Size by Product in 2025 Table Global Cancer Biopharmaceuticals Market Size by Application (2019-2025) (Million US$) Figure Global Cancer Biopharmaceuticals Market Size by Application (2019-2025) Figure Global Cancer Biopharmaceuticals Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Johnson & Johnson Pfizer Novartis Merck GlaxoSmithKline Eli Lilly Agios Pharmaceuticals Bristol-Myers Squibb AstraZeneca Mylan LEO Pharma Boehringer Ingelheim Alexion Pharmaceuticals Elusys Therapeutics